J. A. Barbera (Barcelona, Spain), H. Olschewski (Giessen, Germany)
The vasoactive effects of helospectins I and II in vivo are not mediated by VIP and PACAP1-38 receptors or vasodilator prostaglandins
T. Tsueshita, S. A. Gandhi, H. Onyuksel, I. Rubinstein (Chicago, United States Of America)
|  |
Hypoxic pulmonary vasoconstriction (HPV) shows regional variation in hypoxia response
M. P. Hlastala, W. J. E. Lamm, I. R. Starr, A. Karp, N. L. Polissar, R. W. Glenny (Seattle, United States Of America)
| |
Pulmonary vasoconstriction evoked by d-norfenfluramine but not d-fenfluramine is modified by pre-treatment with an SSRI in the Wistar rat lung
A. Sisodiya, I. C. Kilpatrick, T. W. Higenbottam, C. J. Emery (Sheffield, Nottingham, United Kingdom)
| |
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
R. Schermuly, E. Krupnik, A. Ghofrani, N. Weissmann, F. Rose, A. Schulz, W. Seeger, D. Walmrath, F. Grimminger (Giessen, Germany)
| |
Nitric oxide vs prostacyclin in chronic high-flow pulmonary hypertension
P. Wauthy, S. Abdel Kafi, R. Naeije, S. Brimioulle (Brussels, Belgium)
| |
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients
S. Santos, V. I. Peinado, R. Bastos, J. E. Morales-Blanhir, T. Melgosa, J. Ramirez, J. Roca, R. Rodriguez-Roisin, J. A. Barberà (Barcelona, Spain)
| |
Endothelin-1 and coagulation parameters in pulmonary hypertension
P. Jansa, Z. Susa, J. Homolka, M. Sidova, H. Spundova (Prague, Czech Republic)
| |
Influence of inhaled iloprost on transpulmonary gradient of big-endothelin in patients with pulmonary hypertension
H. Wilkens, M. Bauer, N. Forestier, S. Schneider, G. W. Sybrecht (Homburg, Germany)
| |
Endothelial dysfunction of patients with pulmonary hypertension
N. Karoli, A. Rebrov (Saratov, Russia)
| |
Correlation between the pulmonary hemodynamic and spirometric parameters in patients with chronic obstructive pulmonary disease
O. Yetkin, G. Karabiyikoglu (Ankara, Turkey)
| |
Evaluation of capnography in the diagnosis of pulmonary embolism
O. Sanchez, J. L. Diehl, D. Wermert, H. Sors, J. Y. Fagon, G. Meyer (Paris, France)
| |
Differential diagnosis of PPH vs. CTEPH by spiroergometry with blood gas analysis
H. Olschewski, C. Englisch, R. Wiedemann, B. Enke, G. Afram, R. Schulz, W. Seeger (Giessen, Germany)
| |
Pregnancy and post-partum presentations of pulmonary arteriovenous malformations
R. H. Hyland, M. E. Faughnan (Toronto, Canada)
| |
A survey of the needs and experiences of pulmonary hypertension patients in the UK
T. E. Siddons, I. Armstrong (Sheffield, United Kingdom)
| |
Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH)
J. Demachi, M. Sakuma, T. Takahashi, J. Nawata, O. Kitamukai, J. Ikeda, N. Ishide, K. Shirato (Sendai, Japan)
| |
Right ventricular (RV) diastolic function in patients with pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD)
A. M. Maripov, A. S. Sarybaev, A. S. Sydykov, I. S. Sabirov, M. M. Mirrakhimov (Bishkek, Kyrgyzstan)
| |
Effects of amlodipine on pulmonary haemodynamics in pulmonary hypertension (PH) secondary to chronic obstructive pulmonary disease (COPD)
A. M. Maripov, A. S. Sydykov, I. S. Sabirov, A. S. Sarybaev (Bishkek, Kyrgyzstan)
| |
Effects of inhaled Iloprost on hemodynamics in chronic obstructive pulmonary disease
M. Trinker, C. Hesse, J. Pavek, G. J. Krejs (Bad Gleichenberg, Graz, Austria)
| |